PreVenture Program: An Evidence Based Early Intervention for Teens
Updated: Jul 1
Reposted from PreVenture developed by Dr. Patricia Conrod
The PreVenture program was developed by Dr. Patricia Conrod, a Clinical Psychologist and Professor of Psychiatry at University of Montreal. Dr. Conrod’s research focuses on risk factors for youth substance misuse and mental health problems with a view to understanding why early onset substance use is so highly concurrent with other mental health concerns and future addiction.
The PreVenture Program, a brief, personality-targeted, mental health intervention for adolescents, was created in response to evidence showing how personality factors can be highly predictive of who goes on to develop problems with alcohol and substance misuse.
Multiple randomized controlled trials showed PreVenture to have a strong effect on delaying alcohol and substance use among adolescents. Additionally the program demonstrated a positive effect on several mental health issues that may co-occur with substance misuse.
The PreVenture Program continues to be part of multiple research projects with the aim of creating new adaptations for a wider audience.
The PreVenture Program is a program for youth aged 12-18 that uses personality-focused interventions to promote mental health and reduce the risk of substance use.
Our workshops are designed to help students learn useful coping skills, set long term goals, and channel their personality traits towards achieving them, so that they can thrive in all areas of their lives.
About Dr. Conrod
Dr. Patricia Conrod is a Clinical Psychologist and Professor of Psychiatry at Université de Montreal, as well as an associate member of the departments of Pediatrics and Neuroscience. She holds a Tier 1 Canada Research Chair in Preventative Mental Health and Addiction and the Fondation Julien/Jean et Marcelle Coutu philanthropic research chair in Social and Community Pediatrics and leads a multidisciplinary research team at CHU Sainte-Justine Mother and Child Hospital Centre in Montreal.
Dr. Conrod’s research focuses on causes and consequences of substance use and mental disorders from a developmental perspective. She developed the PreVenture program, a targeted drug and alcohol prevention program which was evaluated in multiple international trials and is now recognised as an evidence-based program in the U.S. Surgeon General’s Report on Addiction, and the UNODC’s International Guidelines on Drug Prevention.
She published over 200 peer-reviewed articles and is cited over 16,000 times in the scientific literature. Her publications are also widely covered in the media, including the New York Times, Wall St Journal, Financial Times, CNN, CBC, and BBC. She is Co-director of the Quebec Network on Suicide, Mood Disorders and Related Disorders, an associate editor of the Canadian Journal of Psychiatry, and director of a number of research consortia, including the ENIGMA Addiction consortium, the CIHR Canadian Cannabis and Psychosis Research Team (CCPRT), the Canadian Underage Substance Use Prevention (CUSP) team, the SSHRC UniVenture Partnership, and the CRISM-Health Canada Emerging Health Threat-At Risk User Research Team.